{"name":"Tasly Pharmaceutical Group Co., Ltd","slug":"tasly-pharmaceutical-group-co-ltd","ticker":"","exchange":"","domain":"tasly.com","description":"","hq":"Tianjin","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Changkang granules","genericName":"Changkang granules","slug":"changkang-granules","indication":"Functional constipation","status":"phase_3"},{"name":"Active drug group","genericName":"Active drug group","slug":"active-drug-group","indication":"Other","status":"marketed"},{"name":"Changkang Granule","genericName":"Changkang Granule","slug":"changkang-granule","indication":"Functional gastrointestinal disorders","status":"phase_2"},{"name":"JS1-1-01","genericName":"JS1-1-01","slug":"js1-1-01","indication":"Other","status":"phase_1"},{"name":"JS1-1-01 high-dose group","genericName":"JS1-1-01 high-dose group","slug":"js1-1-01-high-dose-group","indication":"Other","status":"phase_2"},{"name":"Jia Shen Tablet","genericName":"Jia Shen Tablet","slug":"jia-shen-tablet","indication":"Other","status":"phase_2"},{"name":"Lianxiaxiaopi Granules","genericName":"Lianxiaxiaopi Granules","slug":"lianxiaxiaopi-granules","indication":"Functional dyspepsia","status":"phase_3"},{"name":"Sanhuangjingshimingwan","genericName":"Sanhuangjingshimingwan","slug":"sanhuangjingshimingwan","indication":"Other","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"a simulated agent of Jitongning tablets","genericName":"a simulated agent of Jitongning tablets","slug":"a-simulated-agent-of-jitongning-tablets","indication":"Hypertension","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Antiwei Granules","genericName":"Antiwei Granules","slug":"antiwei-granules","indication":"Cancer-related conditions (specific indication not publicly detailed)","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Jitongning tablets","genericName":"Jitongning tablets","slug":"jitongning-tablets","indication":"Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Qingzhu Granules","genericName":"Qingzhu Granules","slug":"qingzhu-granules","indication":"Heat-related inflammatory conditions","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Susu Xiao'er Zhike Granules","genericName":"Susu Xiao'er Zhike Granules","slug":"susu-xiao-er-zhike-granules","indication":"Treatment of rheumatoid arthritis","status":"phase_3"}]}],"pipeline":[{"name":"Changkang granules","genericName":"Changkang granules","slug":"changkang-granules","phase":"phase_3","mechanism":"Changkang granules is a traditional Chinese medicine formulation that promotes gastrointestinal motility and improves digestive function.","indications":["Functional constipation","Gastrointestinal motility disorders"],"catalyst":""},{"name":"a simulated agent of Jitongning tablets","genericName":"a simulated agent of Jitongning tablets","slug":"a-simulated-agent-of-jitongning-tablets","phase":"phase_3","mechanism":"Jitongning tablets are a simulated agent that works by inhibiting the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure.","indications":["Hypertension"],"catalyst":""},{"name":"Active drug group","genericName":"Active drug group","slug":"active-drug-group","phase":"marketed","mechanism":"This is a broad category descriptor rather than a specific drug, referring to any pharmaceutical compound with active therapeutic properties marketed by Tasly Pharmaceutical Group.","indications":[],"catalyst":""},{"name":"Antiwei Granules","genericName":"Antiwei Granules","slug":"antiwei-granules","phase":"phase_3","mechanism":"Antiwei Granules is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to support anti-tumor activity.","indications":["Cancer-related conditions (specific indication not publicly detailed)"],"catalyst":""},{"name":"Changkang Granule","genericName":"Changkang Granule","slug":"changkang-granule","phase":"phase_2","mechanism":"Changkang Granule is a traditional Chinese medicine formulation that modulates gastrointestinal function and promotes intestinal health through multiple herbal components.","indications":["Functional gastrointestinal disorders","Irritable bowel syndrome"],"catalyst":""},{"name":"JS1-1-01","genericName":"JS1-1-01","slug":"js1-1-01","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JS1-1-01 high-dose group","genericName":"JS1-1-01 high-dose group","slug":"js1-1-01-high-dose-group","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Jia Shen Tablet","genericName":"Jia Shen Tablet","slug":"jia-shen-tablet","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Jitongning tablets","genericName":"Jitongning tablets","slug":"jitongning-tablets","phase":"phase_3","mechanism":"Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow.","indications":["Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear)"],"catalyst":""},{"name":"Lianxiaxiaopi Granules","genericName":"Lianxiaxiaopi Granules","slug":"lianxiaxiaopi-granules","phase":"phase_3","mechanism":"Lianxiaxiaopi Granules is a traditional Chinese medicine formulation that modulates gastrointestinal function and reduces inflammation to treat functional dyspepsia and related digestive disorders.","indications":["Functional dyspepsia","Postprandial distress syndrome"],"catalyst":""},{"name":"Qingzhu Granules","genericName":"Qingzhu Granules","slug":"qingzhu-granules","phase":"phase_3","mechanism":"Qingzhu Granules is a traditional Chinese medicine formulation that clears heat and resolves toxicity to treat heat-related inflammatory conditions.","indications":["Heat-related inflammatory conditions","Acute respiratory infections with heat symptoms"],"catalyst":""},{"name":"Sanhuangjingshimingwan","genericName":"Sanhuangjingshimingwan","slug":"sanhuangjingshimingwan","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Susu Xiao'er Zhike Granules","genericName":"Susu Xiao'er Zhike Granules","slug":"susu-xiao-er-zhike-granules","phase":"phase_3","mechanism":"Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects.","indications":["Treatment of rheumatoid arthritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUU9GX21ndGt0WW1pWjVVOUZld0gtM09LcC1BLURCMjgxckI0VGV4MXduQTJ4eDNGTkN1SU8wcnBkTlFfeW5rMFlJU1FabUVTVFE1eC12czZZMzhKQzdvVU1ORmZSTjhaV3NzaHU3Rjl3WS1taXQ4dHJCV1NMb2dBVmphRldfcUpWOFRxZG9pOElaS1RmR1VtTw?oc=5","date":"2026-03-20","type":"trial","source":"openPR.com","summary":"Breast Cancer Clinical Trial Gains Momentum: 250+ Companies - openPR.com","headline":"Breast Cancer Clinical Trial Gains Momentum: 250+ Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQeWdlc21MNEw5YjhIXzZLMk9RaURROUpFS01ZX0ZWVG1LVEhWSDJ4Nmp2cEhGcklDUDU0dnA5c3RsUnFDU3I5QVdfWjJPSnNRblFWc3p6UElYT2szZHVjZnlJeVpJZF9XbHdxdWtRaDUxOTVRUFZXMWc0Zno4WC1ORWtpOXpzT3k4ZlQ5NHdPNnNwNnJ6dUEwX0JRejZzTmxlbUJCVFFwRERlR29GOS1jeDRJdzJOUQ?oc=5","date":"2026-02-11","type":"deal","source":"Caixin Global","summary":"Tasly’s U.S. Drug Push Falters as Partner Ends Development Deal - Caixin Global","headline":"Tasly’s U.S. Drug Push Falters as Partner Ends Development Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSGd2N1hjV0VqVE9iUzFGWm5fazFaaHA2VXFLcFh2eDMzeGlUazBUREpub2xjRV90OFdicnFrM3MwY3VzekVWcE5JNU1YOElwUlM0SVRFZkJqcmRRdngzVzFxc2tEcVVUUHRpTlJacTMxd3pER2N5dnhIRWsxVkxmN25oakdqQkJVdnZFT211UWVfZmVHOERXUDlydmVMSi1GTURmaVVYYmw?oc=5","date":"2025-08-14","type":"pipeline","source":"The Pharma Letter","summary":"Ribopeutic secures pre-A funding to advance RNA drug discovery - The Pharma Letter","headline":"Ribopeutic secures pre-A funding to advance RNA drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOWlVObG04V1hDdV9wemR1RnJoN1ZNX2o4MDU4V3NJSV9BZjhnOVdKWXRNQ3cyNVVRdU1ReVhmSjkyMVFrbHlHOUFXZjY0am8zVzh6ZHAxVHpiTUYzMXd1eDE0bXd6NTJ2ajlmaHRia29tLVd0R2pHd0g3azZtTWVFLTZVclhRVlJ6SkI3NE1BUkRIZXFoa1hFLXJHVk5UbWRmc0hZXzVWX0JTRV9uY1BPM1VxZHREbDBQZFd1WQ?oc=5","date":"2024-08-05","type":"pipeline","source":"Yicai Global","summary":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million - Yicai Global","headline":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPU1VzNTNRb3Vxd1BLN25QUWlTQkI0dmxwNDBkNkVMV1M4NjczSXdCZDVjTlotNlVqQUJ5TFdFS2drcDhWOGVwX0lQWVNOVVFWUnA5b3g5UFBhZ056ZmRfcGRuT1Jpc1dXeDNOQ2tnS1RCRDBTc3NITUFGeTJ1N2VDNmhFdTR5Tmc2RjJSUVhhRldPQnFP?oc=5","date":"2024-02-08","type":"pipeline","source":"Frontiers","summary":"Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection - Frontiers","headline":"Compound Danshen dripping pills prevent early diabetic retinopathy: roles of vascular protection and neuroprotection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPS3V5dF93QVk2MXo3WEJjSFZZZWczam1qMkNGMTIzLVEyeHNKV0NyZGVwT29vbTU4TlNRM0NjQnBHWGlma3Z3aXhHVl9FWEFadXpQT2dUX0tWRmlOYlJsd3V3NTJYcnZBbjdQUFJyT1JGdkdxMHNxVE5TcEIyTno3eV83QXo4SzUzdmZjU09jVVFIYnVGX1JQdnZ0YkdlTXcyWDBybjM0VE5JaHctNXRndkpkNXFVXzA5SnE2UmtRb3ZQVkpOX2JjcEZ6Zk9OZGgxWTVxV2ZGdDhqdGg2RGtzTnFidmcxdw?oc=5","date":"2020-12-24","type":"pipeline","source":"PharmiWeb.com","summary":"The Traditional Chinese Medicine Market To Traverse The Exponential Growth Trajectory Between 2020–2 - PharmiWeb.com","headline":"The Traditional Chinese Medicine Market To Traverse The Exponential Growth Trajectory Between 2020–2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNRjBxVmkzZENJSFlNWHh4MUhPVEl5bzQzVEhrSE5hOFpYSTFweHVSMFRrZ1d0bGlWY0dFcWRzLUJMdmhDMzR3cWlDczNpbzFMRUpuNHFmRVMwRWtDZ1BJM1hKNUF6RUktbTdTZnRXMWwxeTR0bzgtWmVyQmlmSkZYWTh3?oc=5","date":"2018-07-21","type":"pipeline","source":"China Daily - Global Edition","summary":"Tasly enriches foreign portfolio - China Daily - Global Edition","headline":"Tasly enriches foreign portfolio - China Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFA4NTNmTzY5eXlqM3V0RVNJcFg2MDcwVl94YjJMSkJ0MUdqTnBjODlzQngzQ2pjLXAxS01KX1VpVEZaVi1fWTZ3Z2syOHo3QXltaEdYRFhDOXI?oc=5","date":"2017-06-13","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Tasly Pharmaceutical Group Co., Ltd (600535.SS) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Tasly Pharmaceutical Group Co., Ltd (600535.SS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE0wR1ViZ0Z4OHpfOEU2UVJWX0o2UUlzZjFxV0E1OEVvZzItVVRTR1hXME9TNmx3QkVBUjM5UlhNNG1zVFVHaDBNU2tLYkFCdWU5YnhHX2pEeTNKR1dIV0JzQi10WmYyOU5RSXF0cGU1X0VOV28?oc=5","date":"2015-08-19","type":"pipeline","source":"China Daily","summary":"Getting TCM accepted in US - China Daily","headline":"Getting TCM accepted in US","sentiment":"neutral"}],"patents":[],"drugCount":13,"phaseCounts":{"phase_3":7,"marketed":1,"phase_2":4,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}